VIVA! Communications clinches three awards at the 40th NSW PRIA Golden Target Awards 2016
VIVA! Communications has been recognised for excellence in public relations and communications, clinching three awards across three categories, winning first place in ‘Consumer Marketing’ and receiving two Highly Commended awards in the Health Organisations and Community Relations. Finalists of the of the 40th Public Relations Institute of Australia (PRIA) Golden Target Awards celebrated last night…
Arriving at Spectrum in New York City – GLOBALHealthPR Exchange 2016
Arriving in New York City on Sunday (September 25, 2016), I was immediately taken aback by the sheer size and volume of the place. It’s a phenomenal city to behold. I was met and escorted around Spectrum’s sleek, new office in Battery Park, close to the southernmost tip of Manhattan Island, on floor 26 of…
VIVA! Communications leaps & bounds into 15th year
Leading Australian health and wellness PR agency, VIVA! Communications, has ended 2015-2016 with a record year, a welcome testament to its commitment to excellence in the healthcare PR arena. As the company enters its 15th year of operations, it continues to move from strength to strength both locally and internationally. The only Australian representative for…
Day 1 of Mark Henderson’s GLOBALHealthPR Exchange at Spectrum, Washington, D.C.
Since arriving in Washington DC as part of the GLOBALHealthPR Professional Exchange Program, I’ve been privileged to witness a lot of American history, from Capitol Hill (the seat of the United States Congress and legislative branch of the US Federal Government), to The White House (the official residence and principal workplace of the President of…
VIVA! clinches Highly Commended in Health Organisations category at QLD PRIA Golden Target Awards
If you’ve ever submitted a state-of-the-art PR campaign into an industry competition, you would fully comprehend the process involved. But the effort can certainly pay off. The 2016 PR industry awards season kicked-off last Friday, September 16 in Brisbane with the Public Relations Institute of Australia’s (PRIA) 40th Golden Target Awards (GTAs). PRIA’s Queensland State…
New parents unintentionally placing their babies at risk of SIDS
Many new parents are unknowingly placing their babies at risk of SIDS, according to new research released by the American Academy of Pediatrics on August 15, 2016. The researchers examined video recordings of parents putting their babies to sleep, rather than relying on parental self-reported surveys or police reports post-mortem. More than 160 infants were…
Government to list plethora of treatments for Type 2 diabetes & cervical cancer on PBS from September 1, 2016 – August 22, 2016
On August 14, 2016, Federal Health Minister, The Hon. Sussan Ley MP announced up to 20,000 Australians living with Type 2 diabetes would find it easier and cheaper to access treatments with the Government’s listing of AUD $70 million in new therapies on the Pharmaceutical Benefits Scheme (PBS) from September 1, 2016. A new, once-a-week…
What does the King Review mean for Pharmacy in Australia – August 5, 2016
Following the release of a discussion paper dubbed the “King Review” (as the Productivity Commission’s, Stephen King headed the review panel), which has been developed to review pharmacy remuneration and regulation procedures, discussions have opened up this week around what the review recommends and how this can impact pharmacy. The Federal Government and the Pharmacy…
BREAKING NEWS: Chemmart & Terry White Merger anticipated end of October – August 4, 2016
This morning (August 4, 2016), EBOS Group Limited announced plans to merge its Chemmart business with the Terry White Group businesses, in order to create one of Australia’s largest retail pharmacy groups. In an EBOS investor release published today (August 4, 2016), the wholesaler announced the merge of Chemmart with Terry White would equate to…
Australia’s only locally manufactured QIV now TGA approved – August 2, 2016
Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) received Therapeutic Goods Administration (TGA) approval on July 15, 2016. Afluria Quad™, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older.1 The new quadrivalent vaccine will replace the company’s trivalent vaccine (TIV), Fluvax® for the 2017 flu season. Manufactured by…